skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Female remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells

Hirayama, Alexandre V. ; Gauthier, Jordan ; Hay, Kevin A. ; Voutsinas, Jenna M. ; Wu, Qian ; Gooley, Ted ; Li, Daniel ; Cherian, Sindhu ; Chen, Xueyan ; Pender, Barbara S. ; Hawkins, Reed M. ; Vakil, Aesha ; Steinmetz, Rachel N. ; Acharya, Utkarsh H. ; Cassaday, Ryan D. ; Chapuis, Aude G. ; Dhawale, Tejaswini M. ; Hendrie, Paul C. ; Kiem, Hans-Peter ; Lynch, Ryan C. ; Ramos, Jorge ; Shadman, Mazyar ; Till, Brian G. ; Riddell, Stanley R. ; Maloney, David G. ; Turtle, Cameron J.

Blood, 2019-04, Vol.133 (17), p.1876-1887 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL
Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL
Material Type:
Artigo 		Adicionar ao Meu Espaço

Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL

Rossi, John ; Paczkowski, Patrick ; Shen, Yueh-Wei ; Morse, Kevin ; Flynn, Brianna ; Kaiser, Alaina ; Ng, Colin ; Gallatin, Kyle ; Cain, Tom ; Fan, Rong ; Mackay, Sean ; Heath, James R. ; Rosenberg, Steven A. ; Kochenderfer, James N. ; Zhou, Jing ; Bot, Adrian

Blood, 2018-08, Vol.132 (8), p.804-814 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
3
DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma
DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma

Flinn, Ian W ; Miller, Carole B ; Ardeshna, Kirit M ; Tetreault, Scott ; Assouline, Sarit E ; Mayer, Jiri ; Merli, Michele ; Lunin, Scott D ; Pettitt, Andrew R ; Nagy, Zoltan ; Tournilhac, Olivier ; Abou-Nassar, Karem-Etienne ; Crump, Michael ; Jacobsen, Eric D ; de Vos, Sven ; Kelly, Virginia M ; Shi, Weiliang ; Steelman, Lori ; Le, NgocDiep ; Weaver, David T ; Lustgarten, Stephanie ; Wagner-Johnston, Nina D ; Zinzani, Pier Luigi

Journal of clinical oncology, 2019-04, Vol.37 (11), p.912-922 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma
Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma

Knutson, Sarah K ; Kawano, Satoshi ; Minoshima, Yukinori ; Warholic, Natalie M ; Huang, Kuan-Chun ; Xiao, Yonghong ; Kadowaki, Tadashi ; Uesugi, Mai ; Kuznetsov, Galina ; Kumar, Namita ; Wigle, Tim J ; Klaus, Christine R ; Allain, Christina J ; Raimondi, Alejandra ; Waters, Nigel J ; Smith, Jesse J ; Porter-Scott, Margaret ; Chesworth, Richard ; Moyer, Mikel P ; Copeland, Robert A ; Richon, Victoria M ; Uenaka, Toshimitsu ; Pollock, Roy M ; Kuntz, Kevin W ; Yokoi, Akira ; Keilhack, Heike

Molecular cancer therapeutics, 2014-04, Vol.13 (4), p.842-854 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
5
Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial
Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial

Sehn, Laurie H, Dr ; Chua, Neil, MD ; Mayer, Jiri, Prof ; Dueck, Gregg, MD ; Trněný, Marek, Prof ; Bouabdallah, Kamal, MD ; Fowler, Nathan, MD ; Delwail, Vincent, MD ; Press, Oliver, Prof ; Salles, Gilles, MD ; Gribben, John, Prof ; Lennard, Anne, MBBS ; Lugtenburg, Pieternella J, MD ; Dimier, Natalie, MSc ; Wassner-Fritsch, Elisabeth, PharmD ; Fingerle-Rowson, Günter, MD ; Cheson, Bruce D, Prof

The lancet oncology, 2016-08, Vol.17 (8), p.1081-1093 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma

Gopal, Ajay K ; Kahl, Brad S ; de Vos, Sven ; Wagner-Johnston, Nina D ; Schuster, Stephen J ; Jurczak, Wojciech J ; Flinn, Ian W ; Flowers, Christopher R ; Martin, Peter ; Viardot, Andreas ; Blum, Kristie A ; Goy, Andre H ; Davies, Andrew J ; Zinzani, Pier Luigi ; Dreyling, Martin ; Johnson, Dave ; Miller, Langdon L ; Holes, Leanne ; Li, Daniel ; Dansey, Roger D ; Godfrey, Wayne R ; Salles, Gilles A

The New England journal of medicine, 2014-03, Vol.370 (11), p.1008-1018 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
7
Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study
Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study

Palanca-Wessels, Maria Corinna A, Dr ; Czuczman, Myron, Prof ; Salles, Gilles, Prof ; Assouline, Sarit, MD ; Sehn, Laurie H, MD ; Flinn, Ian, MD ; Patel, Manish R, MD ; Sangha, Randeep, MD ; Hagenbeek, Anton, MD ; Advani, Ranjana, MD ; Tilly, Herve, Prof ; Casasnovas, Olivier, MD ; Press, Oliver W, Prof ; Yalamanchili, Sreeni, PharmD ; Kahn, Robert, MD ; Dere, Randall C, BSc ; Lu, Dan, PhD ; Jones, Surai, MS ; Jones, Cheryl, ScD ; Chu, Yu-Waye, MD ; Morschhauser, Franck, Prof

The lancet oncology, 2015-06, Vol.16 (6), p.704-715 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas
Material Type:
Artigo 		Adicionar ao Meu Espaço

First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas

Patnaik, A. ; Appleman, L.J. ; Tolcher, A.W. ; Papadopoulos, K.P. ; Beeram, M. ; Rasco, D.W. ; Weiss, G.J. ; Sachdev, J.C. ; Chadha, M. ; Fulk, M. ; Ejadi, S. ; Mountz, J.M. ; Lotze, M.T. ; Toledo, F.G.S. ; Chu, E. ; Jeffers, M. ; Peña, C. ; Xia, C. ; Reif, S. ; Genvresse, I. ; Ramanathan, R.K.

Annals of oncology, 2016-10, Vol.27 (10), p.1928-1940 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial
Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial

Fowler, Nathan H, Dr ; Davis, R Eric, MD ; Rawal, Seema, PhD ; Nastoupil, Loretta, MD ; Hagemeister, Fredrick B, Prof ; McLaughlin, Peter, Prof ; Kwak, Larry W, Prof ; Romaguera, Jorge E, Prof ; Fanale, Michelle A, MD ; Fayad, Luis E, MD ; Westin, Jason R, MD ; Shah, Jatin, MD ; Orlowski, Robert Z, Prof ; Wang, Michael, Prof ; Turturro, Francesco, Prof ; Oki, Yasuhiro, MD ; Claret, Linda C, RN ; Feng, Lei, MS ; Baladandayuthapani, Veerabhadran, PhD ; Muzzafar, Tariq, MD ; Tsai, Kenneth Y, MD ; Samaniego, Felipe, MD ; Neelapu, Sattva S, MD

The lancet oncology, 2014-11, Vol.15 (12), p.1311-1318 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
A phase 1b study of dual PD-1 and CTLA-4 or KIR blockade in patients with relapsed/refractory lymphoid malignancies
A phase 1b study of dual PD-1 and CTLA-4 or KIR blockade in patients with relapsed/refractory lymphoid malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 1b study of dual PD-1 and CTLA-4 or KIR blockade in patients with relapsed/refractory lymphoid malignancies

Armand, Philippe ; Lesokhin, Alexander ; Borrello, Ivan ; Timmerman, John ; Gutierrez, Martin ; Zhu, Lili ; Popa McKiver, Mihaela ; Ansell, Stephen M

Leukemia, 2021-03, Vol.35 (3), p.777-786 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (2.891)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (3.142)
  2. Anais de Congresso  (4)
  3. magazinearticle  (3)
  4. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1976  (176)
  2. 1976Até1987  (293)
  3. 1988Até1999  (986)
  4. 2000Até2012  (1.176)
  5. Após 2012  (522)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (2.996)
  2. Japonês  (396)
  3. Alemão  (58)
  4. Francês  (30)
  5. Espanhol  (27)
  6. Chinês  (12)
  7. Italiano  (7)
  8. Russo  (5)
  9. Norueguês  (4)
  10. Holandês  (4)
  11. Português  (3)
  12. Hebraico  (1)
  13. Dinamarquês  (1)
  14. Serbian  (1)
  15. Tcheco  (1)
  16. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.